symplr snaps up healthcare provide chain administration firm Greenlight Medical

0
35
Best Health Product


Healthcare operations software program developer symplr introduced its plans to purchase medical provide chain administration software program firm GreenLight Medical for an undisclosed sum. This information comes simply months after symplr sounded the acquisition of Midas Health Analytics Solutions for $340 million. 

As a part of the deal, symplr will purchase GreenLight’s software program, which is targeted on giving well being organizations knowledge for “evaluating, buying and deploying new medical expertise, streamlining collaborative and compliant buying choices.” 

Based in 2014, GreenLight Medical has roughly $1.2 million in funding, based on Crunchbase

WHY IT MATTERS 

Based on a 2021 Kaufman Hall report, 99% of well being organizations have reported difficulties in provide procurement. symplr is pitching this acquisition as a method to assist construct out its product line and supply its purchasers extra companies within the provide chain administration enviornment. 

“GreenLight Medical is a pure complement to our healthcare operations portfolio. The mix of symplr’s Spend Administration providing and GreenLight’s software program platform will allow monetary leaders throughout well being programs to make extra knowledgeable spending choices,” BJ Schaknowski, CEO of symplr, stated in an announcement. “Healthcare programs at present are looking for built-in and linked enterprise options. Our imaginative and prescient for symplr Spend Administration is to ship streamlined provide chain choice assist, making it simpler for leaders to make knowledgeable, well timed, value-based, and defensible buy choices.”

THE LARGER TREND

symplr reviews that that is its sixteenth acquisition within the final six years. In September, the corporate bought medical communication platform Halo Health for an undisclosed sum. Based in 2006, the Texas firm is backed by non-public fairness firm Clearlake Capital Group

 


Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here